Error: Could not add to watchlist. X
+ Watchlist

Regulus Therapeutics Inc

RGLS:US
NASDAQ GM
1.40
USD
0.15
12.00%
As of 8:10 PM EDT 3/24/2017
Open
1.35
Day Range
1.25 - 1.55
Volume
4,282,684
Previous Close
1.25
52Wk Range
0.94 - 8.90
1 Yr Return
-78.26%
Before it's here, it's on the Bloomberg Terminal.
Learn More
Open
1.35
Day Range
1.25 - 1.55
Volume
4,282,684
Previous Close
1.25
52Wk Range
0.94 - 8.90
1 Yr Return
-78.26%
YTD Return
-37.78%
Current P/E Ratio (TTM)
-
Earnings per Share (USD) (TTM)
-1.55
Market Cap (m USD)
74.105
Shares Outstanding (m)
52.932
Price/Sales (TTM)
61.87
Dividend Indicated Gross Yield
-
Sector
Health Care
% Price Change
-0.03%
% Price Change
-0.13%

Related Videos

There are currently no related videos for this ticker. Please check back later.
There are currently no news stories for this ticker. Please check back later.
Profile
Regulus Therapeutics Inc. operates within the biopharmaceutical industry. The Company's products aim to treat and prevent hepatitis C infections, cardiovascular, fibrosis, oncology, immuno-inflammatory, and metabolic diseases. Regulas research consists of scientists from across the world.
Address
3545 John Hopkins Court
Suite 210
San Diego, CA 92121
United States
Phone
1-858-202-6300
Show More